Proqr Therapeutics Nv
ProQR Therapeutics develops an Axiomer RNA‑base editing platform to treat genetic disorders, from cholestatic liver disease (AX‑0810) and cardiovascular disease (AX‑1412) to metabolic and CNS disorders. Partnerships with Ionis, Radboud, Vico, Eli Lilly enhance pipeline reach.
Headquarters: Netherlands (NLD)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Professional Services
- Industry: Biotechnology Research
- Employees: 166
- HQ: Leiden
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.